C1QBP and stroke disorder: Although C1 inhibitors have been used as targeted therapies for edema formation following stroke (Weiss et al., 2020; Mercurio et al., 2021), the role gC1qR plays in edema formation post-stroke and its potential for being a therapeutic target have yet to be investigated.